The Weight of Wellness: When Perks Become Policy

Bank of America has committed $250 million annually to providing its employees with GLP-1 weight loss medications, a move that reflects the growing trend of companies investing in employee health. According to CEO Brian Moynihan, this investment is paying off, with employees showing significant improvements in their well-being.

The justification for this expensive perk lies in the increasing willingness of workers to switch jobs for access to these medications. With nearly a third of employees willing to make such a move, companies are under pressure to compete in the war for talent. As GLP-1s have become more widely available and affordable – even Amazon’s One Medical offers them for as low as $25 a month – employers feel compelled to keep up.

But this trend raises fundamental questions about the role of corporate benefactors in employee health. By essentially buying employees into wellness through expensive medication, companies are inserting themselves into intimate decisions about how individuals live their lives and what they do with their bodies. This commodification of health erodes the boundaries between employer and employee, blurring the lines of what it means to be well.

The numbers tell a story: by 2026, over a quarter of large corporations plan to expand their GLP-1 coverage criteria, while 11% have already dropped or plan to drop coverage for weight-loss purposes. Cigna cited “increased availability” and “new options,” while HCA Healthcare stopped covering the drugs after employee use shot up by 90% in 2025.

This trend speaks to a broader issue: the normalization of corporate influence over individual health decisions. When companies write checks for expensive medications, they’re not just providing benefits – they’re dictating how employees should live their lives. This raises concerns about the long-term implications of such a trend. Will companies start incentivizing or penalizing employees based on arbitrary standards of wellness?

Bank of America’s gamble may pay off in the short term, but it’s a Faustian bargain that comes with significant risks. Moynihan acknowledges that some benefits won’t be seen for years after employees have left the company – and even then, there are no guarantees.

The real question is: what does this mean for us? Will we continue to trade our autonomy for the promise of a healthier life, or will we start to push back against the creeping paternalism of corporate wellness? As the trend continues to unfold, it’s clear that we need to take a closer look at what we’re willing to sacrifice in the name of “wellness.”